These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32804276)

  • 1.
    Delage JA; Faivre-Chauvet A; Fierle JK; Gnesin S; Schaefer N; Coukos G; Dunn SM; Viertl D; Prior JO
    EJNMMI Res; 2020 Aug; 10(1):98. PubMed ID: 32804276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [
    Delage JA; Faivre-Chauvet A; Barbet J; Fierle JK; Schaefer N; Coukos G; Viertl D; Dunn SM; Gnesin S; Prior JO
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33451158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety.
    Delage JA; Gnesin S; Prior JO; Barbet J; Le Saëc P; Marionneau-Lambot S; Gouard S; Chérel M; Bourgeois M; Schaefer N; Viertl D; Fierle JK; Dunn SM; Faivre-Chauvet A
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From bench to bedside:
    Gnesin S; Chouin N; Cherel M; Dunn SM; Schaefer N; Faivre-Chauvet A; Prior JO; Delage JA
    EJNMMI Res; 2023 Jun; 13(1):59. PubMed ID: 37314509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Evaluation and Dosimetry of [
    Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
    Mol Imaging Biol; 2020 Aug; 22(4):979-991. PubMed ID: 31993928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panitumumab Modified with Metal-Chelating Polymers (MCP) Complexed to
    Aghevlian S; Lu Y; Winnik MA; Hedley DW; Reilly RM
    Mol Pharm; 2018 Mar; 15(3):1150-1159. PubMed ID: 29314858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment.
    Li D; Ding L; Chen Y; Wang Z; Zeng Z; Ma X; Huang H; Li H; Qian X; Yang Z; Zhu H
    Eur J Med Chem; 2024 Feb; 266():116134. PubMed ID: 38266552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and Preclinical Evaluation of Novel Radiolabeled Anti-Fibroblast Activation Protein-α Recombinant Antibodies.
    Xu J; Li S; Xu S; Dai J; Luo Z; Cui J; Cai F; Geng C; Wang Z; Tang X
    Cancer Biother Radiopharm; 2023 Dec; 38(10):726-737. PubMed ID: 35612467
    [No Abstract]   [Full Text] [Related]  

  • 9. Site-specific Conjugation of 6 DOTA Chelators to a CA19-9-targeting scFv-Fc Antibody for Imaging and Therapy.
    Chen LA; Yu YH; Tian WT; Lin WC; Grauffel C; Wu CY; Chen CL; Lim C; Chu HM; Chang TW; Peng CJ
    J Med Chem; 2023 Aug; 66(15):10604-10616. PubMed ID: 37462154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
    Cheal SM; Xu H; Guo HF; Patel M; Punzalan B; Fung EK; Lee SG; Bell M; Singh M; Jungbluth AA; Zanzonico PB; Piersigilli A; Larson SM; Cheung NV
    Theranostics; 2018; 8(18):5106-5125. PubMed ID: 30429889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of
    Banerjee SR; Kumar V; Lisok A; Plyku D; Nováková Z; Brummet M; Wharram B; Barinka C; Hobbs R; Pomper MG
    J Nucl Med; 2019 Mar; 60(3):400-406. PubMed ID: 30237212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of the theranostic potential of
    Wu Y; Li T; Zhang X; Jing H; Li F; Huo L
    EJNMMI Radiopharm Chem; 2024 Jan; 9(1):5. PubMed ID: 38194043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
    Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
    J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
    Deshayes E; Ladjohounlou R; Le Fur P; Pichard A; Lozza C; Boudousq V; Sevestre S; Jarlier M; Kashani R; Koch J; Sosabowski J; Foster J; Chouin N; Bruchertseifer F; Morgenstern A; Kotzki PO; Navarro-Teulon I; Pouget JP
    J Nucl Med; 2018 Aug; 59(8):1234-1242. PubMed ID: 29674421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
    Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM
    J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Lau J; Kwon D; Rousseau E; Zhang Z; Zeisler J; Uribe CF; Kuo HT; Zhang C; Lin KS; Bénard F
    Mol Pharm; 2019 Nov; 16(11):4688-4695. PubMed ID: 31545614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of DOTA Chelators on Radiochemical Purity and Biodistribution of
    Karczmarczyk U; Wojdowska W; Mikołajczak R; Maurin M; Laszuk E; Garnuszek P
    Iran J Pharm Res; 2018; 17(4):1201-1208. PubMed ID: 30568680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
    Persson M; Rasmussen P; Madsen J; Ploug M; Kjaer A
    Nucl Med Biol; 2012 Oct; 39(7):962-9. PubMed ID: 22739362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.